stage of initial investment

Pre-seed

year of initial investment

2022

location

France

View Website

AdipoPharma

Adipocyte targeting therapuetic aimed at improving insulin resistance

about

AdipoPharma is a French biotechnology company focused on developing a first-in-class therapeutic peptide for diabetes through their proprietary approach to understanding the role of adipocyte cells in lipid homeostasis.

why ggc invested

Autem id id odio totam ut consequatur quia. Totam accusantium mollitia id qui vel et nihil inventore recusandae. Ratione ea sunt. Voluptatem sed reiciendis

founder

Vincent Marion PhD

AdipoPharma

Life Science

stage of initial investment

Pre-seed

year of initial investment

2018

location

California

View Website

Aluna

At-home lung function and asthma management platform

about

AlunaCare is a digital health company that provides a comprehensive asthma management platform for patients and healthcare providers.

why ggc invested

Autem id id odio totam ut consequatur quia. Totam accusantium mollitia id qui vel et nihil inventore recusandae. Ratione ea sunt. Voluptatem sed reiciendis

founder

Charvi Shetty

Aluna

Life Science

stage of initial investment

Series B

year of initial investment

2021

location

California

View Website

Angiocrine Bioscience

Targeting endothelial cells for hematologic diseases

about

Angiocrine Bioscience is a clinical stage biotechnology company that develops innovative cell therapies for hematologic diseases and cancer by targeting the endothelial cells that regulate blood and lymphatic vessels.

why ggc invested

founder

Paul Finnegan, M.D., M.B.A.

Angiocrine Bioscience

Life Science

stage of initial investment

Seed

year of initial investment

2022

location

San Francisco, California

View Website

Aralez Bio

Harnessing enzymes to create amino acids used in pharmaceutical manufacturing

about

Aralez Bio is a biocatalyis company that has invented a novel enzymatic method for synthesizing noncanonical amino acids, also called unusual or unnatural amino acids. These amino acids are critical for the development of peptide therapeutics, among many other uses.

why ggc invested

founder

Tina Boville

Aralez Bio

Life Science

stage of initial investment

Preseed

year of initial investment

2020

location

Newberry, Indiana

View Website

Ateios

State-of-the-Art Solid-State Battery Technology for Wearable and IoT Devices; Delivering Unmatched Safety, Performance, and Reliability

about

Ateios is a cutting-edge technology company that specializes in the design and production of ultra-thin, lightweight, and flexible solid-state batteries that are engineered to power the next generation of wearable and IoT devices, offering unprecedented levels of safety, performance, and reliability

why ggc invested

founder

Rajan Kumar

Ateios

Data Science

stage of initial investment

Seed

year of initial investment

2022

location

Philadelphia, Pennsylvania

View Website

Avisi

Nanotechnology solutions for the treatment of glaucoma

about

Avisi Technologies is medical device company developing solutions for the diagnosis, treatment, and management of a wide range of ophthalmic diseases. Their flagship product, VisiPlate, is a groundbreaking implantable device that offers a minimally invasive solution for treating glaucoma, helping to reduce intraocular pressure and preserve vision over time.

why ggc invested

founder

Rui Jing Jiang

Avisi

Life Science

stage of initial investment

Preseed

year of initial investment

2018

location

Washington DC

View Website

Base Operations

Advanced Risk Management Solutions for High-Risk Environments, Leveraging Data Analytics, Artificial Intelligence, and Satellite Imagery

about

Base Operations enhances and scales security capabilities with granular, street-level threat intelligence. Investigate important locations on-demand to identify the threats that matter most and provide data-backed recommendations that expand and showcase the value of your security team.

why ggc invested

founder

Cory Siskind

Base Operations

Data Science

stage of initial investment

Seed

year of initial investment

2021

location

San Francisco, California

View Website

Blue Ocean Gear

Building sensored tracking buoys to address the commercial fishing industry's informational and environmental challenges

about

Blue Ocean Gear creates high-tech buoys that can track gear in the marine environment, including detecting and locating lost or entangled fishing gear. These smart devices help fishermen save money while protecting the ocean environment.

why ggc invested

founder

Kortney Opshaug

Blue Ocean Gear

GreenTech

stage of initial investment

Seed

year of initial investment

2019

location

California

View Website

Bone Health

Mechanical stimulation belt for bone diseases

about

Bone Health Technologies is the of medical devices designed to provide relief from osteopenia and osteoporosis. Their flagship, OsteoBoost, is based on a mechanical stimulation product that mimics weight-bearing exercise and relies on effective whole-body vibration technology, enabling people suffering from bone mass problems to access an effective non-drug intervention

why ggc invested

founder

Laura Yecies

Bone Health

Life Science

stage of initial investment

Series A

year of initial investment

2022

location

Boston, Massachusetts

View Website

Boston Materials

Boston Materials manufactures Z-axis Carbon Fiber products that can revolutionize the $130B+ lightweight materials market

about

Developers of high-performance materials to enable manufacturers of industrial and consumer products to break through their design trade-offs with new materials.

why ggc invested

founder

Anvesh Gurijala

Boston Materials

GreenTech

stage of initial investment

Series A

year of initial investment

2022

location

Boston, Massachusetts

View Website

Bounce Imaging

Throwable omnidirectional/360 cameras for first responders

about

Designs and manufactures low-cost, throwable 360-degree cameras powered by best-in-class real-time omnidirectional image stitching algorithms, keeping soldiers, police, and other first-responders safer in critical environments

why ggc invested

founder

Francisco Aguilar

Bounce Imaging

Data Science

stage of initial investment

Preseed

year of initial investment

2023

location

Cambridge, Massachusetts

View Website

Cambridge Terahertz

Scalable, cost-effective, portable imaging and scanning platform using cutting edge terahertz technology

about

First-of-its-kind solid state portable Terehertz radar imaging platform using non-ionizing, high frequency radiowaves with wide applications ranging from security, medicine, telecommunications and more

why ggc invested

founder

Nathan Monroe PhD

Cambridge Terahertz

Data Sciences

stage of initial investment

Series A

year of initial investment

2020

location

Massachusetts

View Website

Coagulo Medical Technologies

Diagnostic platform for coagulation biomarkers using microfluidic technology

about

Coagulo Medical Technologies is a medical device company that has developed the world’s first portable precision-medicine platform capable of pinpointing blood clots and abnormalities within 10 minutes, enabling better healthcare outcomes for everyone, especially those on blood thinners.

why ggc invested

founder

Jarrod Niebloom

Coagulo Medical Technologies

Life Sciences

stage of initial investment

Seed

year of initial investment

2019

location

Massachusetts

View Website

Databento

A simpler, faster way to get market data

about

Self service pay per use platform to instantly pick up live financial exchange feeds and historical data

why ggc invested

founder

Christina Qi

Databento

Data Science

stage of initial investment

Seed

year of initial investment

2017

location

South Carolina

View Website

Dynepic

Open digital infrastructure ecosystem for XR creators

about

Best in class digital infrastructure platform democraticing XR and enabling industry leaders to create XR training tools and applications

why ggc invested

founder

Krissa Watry

Dynepic

Data Science

stage of initial investment

Preseed

year of initial investment

2019

location

Massachusetts

View Website

Eden GeoPower

Electrical reservoir stimulation technology boosting capabilities to recover natural resources

about

First-of-its-kind Electrical Reservoir Stimulation technology to increase the recovery of natural resources and improve the economics of resource extraction with minimal environmental impact

why ggc invested

founder

Paris Smalls

Eden GeoPower

GreenTech

stage of initial investment

Preseed

year of initial investment

2020

location

Massachusetts

View Website

Encora Therapeutics

Non invasive treatment to relieve tremors of the hand

about

Encora is a medical device startup that is working on building affordable, non-invasive neurostimulation devices for those affected by movement disorders, including Parkinson’s.

why ggc invested

founder

Daniel Carballo

Encora Therapeutics

Life Science

stage of initial investment

Preseed

year of initial investment

2021

location

New York

View Website

Fermata

Data and visialization driven platform for legal case mangement to accelerate the speed of investigations

about

Fermata is building investigation performance and management tools at the intersection of software engineering, data science and artificial intelligence

why ggc invested

founder

Amanda van Goetz

Fermata

Data Science

stage of initial investment

Preseed

year of initial investment

2019

location

Massachusetts

View Website

Fisherman

"No effort web" solutions hooking SMB customers to improve their web presence

about

Fisherman is building software that integrates with point of sales and other enterprise technology and automatically generates complete, and live-ready websites for SMB customers

why ggc invested

founder

Ameet Kallarackal

Fisherman

Data Science

stage of initial investment

Seed

year of initial investment

2019

location

North Carolina

View Website

Fluree

Open source graph database solutions for secure, connected and trusted data ecosystems

about

Fluree offers the full spectrum of data management tooling for data-centric organizations – from the first step of integrating and migrating legacy system data infrastructure through to building modernized operational and analytical data infrastructure.

why ggc invested

founder

Brian Platz

Fluree

Data Science

stage of initial investment

Series D

year of initial investment

2021

location

Massachusetts

View Website

Form Energy

Reshaping the global electic system by creating a new class oflow cost multi-day storage systems

about

Starting with a iron-air battery capable of storing electricity for 100 hours at system costs competitive with legacy power plants, Form energy seeks to develop a new class of cost-effective, multi-day energy storage systems that in concert will lead to a reliable and fully-renewable electric grid year-round

why ggc invested

founder

Mateo Jaramillo

Form Energy

GreenTech

stage of initial investment

Preseed

year of initial investment

2022

location

California

View Website

GoPower EV

Turnkey subscription for multi-family EV charging

about

Charging solutions for multi-family housing that is easy to install and manage while providing a seamless service for tenants

why ggc invested

founder

John Reister

GoPower EV

GreenTech

stage of initial investment

Seed

year of initial investment

2019

location

Texas

View Website

IRYS

Optimizing collabotration and driving actionable community insights

about

Irys is an all-in-one, modular collaboration solution that eliminates the need to swap between multiple apps to gather data and communicate

why ggc invested

founder

Beto Altamirano

IRYS

Data Science

stage of initial investment

Series A

year of initial investment

2021

location

Massachusetts

View Website

Impact Biosystems

Hardware for muscle scanning

about

Impact Biosystems is a consumer health startup in the Boston area developing adaptive hardware and software solutions in the health and fitness space. Their goal is to make athletes of all varieties uniquely feel better, perform at their peak, and help them live longer.

why ggc invested

founder

Bridget Hunter-Jones

Impact Biosystems

Life Sciences

stage of initial investment

Preseed

year of initial investment

2018

location

South Carolina

View Website

Interloop

All-in one, flexible, full stack data platform

about

Scalable seamless full-stack data platform that is easy to manage and maintain and includes data engineering service expertise enabling customers to focus on insights and accelerating growth

why ggc invested

founder

Tony Berry

Interloop

Data Science

stage of initial investment

Seed

year of initial investment

2022

location

Toronto, Ontario

View Website

Lemurian Labs

Unlocking the hidden performance potential in silicon to enable next generation autonomy

about

Creators of next generation silicon and chips that will surpass legacy compute power to improve the performance and capabilities of autonomous robotics and applications

why ggc invested

founder

Jay Dawani

Lemurian Labs

Data Science

stage of initial investment

Seed

year of initial investment

2019

location

Boston, Massachusetts

View Website

Leuko

Non-invasive white blood cell monitoring

about

Leuko is a medical device startup that is developing the first device for non-invasive white cell monitoring in cancer chemotherapy patients. By removing the need for a blood draw, millions of immunosuppressed patients can now be tested more frequently, moving towards improved quality of life and improved clinical outcomes.

why ggc invested

founder

Carlos Castro-Gonzalez

Leuko

Life Science, Data Science

stage of initial investment

Series A

year of initial investment

2021

location

Palo Alto, California

View Website

Liminal

Improving data and analytics in EV battery manufacturing to empower a sustainable future

about

Developers of an advanced EV manufacturing data and analytics platform that provides visibility inside batteries throughout the manufacturing process, enabling customers to catch and resolve data or production flaws in real-time

why ggc invested

founder

Andrew Hsieh

Liminal

GreenTech

stage of initial investment

Series A

year of initial investment

2019

location

North Carolina

View Website

Lindy Biosciences

High concentration suspensions that enable for sub-cutaneous delivery

about

Lindy Biosciences is a drug delivery startup that creates protein-based therapeutic formulations, using their proprietary Microglassification technology. This process gently removes a majority of the water from solutions of proteins, or other biologics, resulting in solid, spherical, amorphous microbeads, for subcutaneous injectable formulations.

why ggc invested

founder

Deborah Bitterfield

Lindy Biosciences

Life Science

stage of initial investment

Preseed

year of initial investment

2023

location

Chicago, IL

View Website

MFNS

Economic, efficient, and eco-friendly water cleanup solution via patented nanostructured coating

about

Using breakthrough patented nanotechnology, MFNS provides a "complete solution" to local environemntal challenges - developing procedures with minimal post-cleanup footprints and promoting environmental stewardship

why ggc invested

founder

Vinayak Dravid

MFNS

GreenTech

stage of initial investment

Preseed

year of initial investment

2020

location

North Carolina

View Website

Nala Membranes

Revolutionizing Water Treatment with Sustainable and Cost-Effective Nanofiltration Solutions

about

Their unique membrane technology offers a sustainable and cost-effective solution for water treatment, removing contaminants and pollutants from water sources. The company's innovative products have a wide range of applications, including drinking water treatment, wastewater treatment, and industrial processes.

why ggc invested

founder

Susan Mecham

Nala Membranes

GreenTech

stage of initial investment

Preseed

year of initial investment

2019

location

South Carolina

View Website

Obsidio

Embolic device to control bleeding/hemorrhaging

about

Obsidio was an medical device startup that developed a revolutionary Gel Embolic Material (GEM). The breakthrough technology offers promising alternative for endovascular embolization with applications in treatment of hemorrhage, aneurysm and cancer. Obsidio was acquired by Boston Scientific in 2022.

why ggc invested

founder

Ehsan Jabbarzadeh

Obsidio

Life Sciences

stage of initial investment

Seed

year of initial investment

2020

location

Lafeyette, Colorado

View Website

OrbitFab

In-Space Refueling with Advanced Propellant Supply Systems and Innovative Satellite Services

about

Pioneering the development and deployment of advanced propellant supply systems for in-space refueling of satellites and spacecraft. Their innovative technologies enable spacecraft to refuel in orbit, extending their operational life and reducing costs

why ggc invested

founder

Daniel Faber

OrbitFab

GreenTech

stage of initial investment

Seed

year of initial investment

2020

location

Massachusetts

View Website

Piction Health

Simplifying dermatology care via collaborative tooling

about

Empowering physicians with AI-Powered Diagnostic Tools and Secure Collaboration Platform

why ggc invested

founder

Susan Conover

Piction Health

Life Sciences

stage of initial investment

Seed

year of initial investment

2019

location

Washington DC

View Website

Pienso

Codefree interface enabling customers to tailor any model with their own data

about

Platform to democratize machine learning, making it easy to turn text data into insights for non-programmers

why ggc invested

founder

Birago Jones

Pienso

Data Sciences

stage of initial investment

Seed

year of initial investment

2022

location

Minneapolis, Minnesota

View Website

Pleural Dynamics

Device aimed at removing fluid collections for cancer patients

about

Pleural Dynamics is a medical device startup that is focused on treating and managing chronic, recurrent fluid collections within the body. The two main indications that Pleural Dynamics focus on are recurrent pleural effusions caused by cancer and refractory ascites.

why ggc invested

founder

Martin Mayse, M.D.

Pleural Dynamics

Life Sciences

stage of initial investment

Seed

year of initial investment

2018

location

North Carolina

View Website

Pryon

"AI-Powered Enterprise Automation and Augmented Intelligence"" "

about

Highly customizable, innovative platform driving enterprise automation, augmented intelligence, and collaboration across industries and organizations big and small

why ggc invested

founder

Igor Jablokov

Pryon

Data Sciences,

stage of initial investment

Series A

year of initial investment

2017

location

South Carolina

View Website

Questis

Workforce financial empowerment company providing a complete personal finance solution that benefits people, employers, and advisors

about

Fintech company enabling businesses to provide personalized finance guidance and education to their employees. Questis' platform is highly scalable, making it ideal for businesses of all sizes, and it's user-friendly interface ensures that employees can easily access and utilize the tools and resources available to them.

why ggc invested

founder

Steve Wilbourne

Questis

Data Science

stage of initial investment

Series A

year of initial investment

2019

location

Colorado

View Website

Radia

Renewable energy, aerospace, environment and transportation solution services

about

Accelerating the energy transition with proprietary solutions enhancing offshore wind turbine support structures

why ggc invested

founder

Mark Lundstrom

Radia

GreenTech

stage of initial investment

Preseed

year of initial investment

2019

location

Massachusetts

View Website

Radical Plastics

Blending convensional plastics with proprietary naturally occuring catalysts to bring biodegradable solutions to market

about

Developers proprietary catalysts that act as regulat plastics, but if they end up in the environment, the converts into a material that microbes recognize as food. This allows them to metabolize the material turning it into biomass, CO2 and water. Radical Plastics compounds biodegrade fully in the environment leaving no residue, no toxic substances and no microplastics.

why ggc invested

founder

Kristin Taylor

Radical Plastics

GreenTech

stage of initial investment

Preseed

year of initial investment

2019

location

South Carolina

View Website

Reflection Analytics

Digital investment platform and services that enable transparency and customized portfolio creation based on an investor's values

about

Provides advisors and investors with the transparency and analytical tools to become experts in custom analysis and ESG analysis in a quick and user-friendly technology ecosystem

why ggc invested

founder

Jason Britton

Reflection Analytics

Data Science

stage of initial investment

Seed

year of initial investment

2017

location

New York

View Website

Republic

Enabling individuals to invest in private, high-growth potential opportunities

about

Curated private investing platform enabling investments in high growth opportunities including startups, crypto, real estate, art, music and more

why ggc invested

founder

Ken Nguyen

Republic

Data Science

stage of initial investment

Seed

year of initial investment

2018

location

Massachusetts

View Website

ReviveMed

AI Driven Drug Discovery

about

ReviveMed is an AI-driven drug discovery platform focused on discovering therapeutics for metabolic diseases, including fatty liver diseases. ReviveMed is a pioneer in the intersection of AI and metabolomics, located in the heart of biotech innovation in Cambridge, MA. ReviveMed uniquely overcomes the difficulties of identifying a large set of metabolites for each patient, based on the technology that ReviveMed’s founders developed at MIT and published in Nature Methods.

why ggc invested

founder

Leila Pirhaji

ReviveMed

Data Science, Life Science

stage of initial investment

Seed

year of initial investment

2019

location

South Carolina

View Website

Rheos

Polarized floatable nautical eyewear with 100% UV protection

about

Floating sunglasses designed for watersports enthusiasts providing style and eye protection in both wet and dry conditions

why ggc invested

founder

Jake Berton

Rheos

stage of initial investment

Seed

year of initial investment

2023

location

Boston, Massachusetts

View Website

Robigo

Engineered microbes targeted for plant diseases

about

Robigo is a biomanufacturing company developing a microbial platform technology that leverages bioengineering and data science to precisely protect crops from disease while being safe to beneficial microorganisms, pollinators, humans, and the environment.

why ggc invested

founder

Andee Wallace

Robigo

GreenTech, Life Science

stage of initial investment

Seed

year of initial investment

2017

location

Massachusetts

View Website

Skyhawk Therapeutics

Small molecules that modify RNA expression

about

Skyhawk Therapeutics is a pre-clinical stage biotechnology company that uses proprietary structural, kinetic, and computational models to invent small molecules that modify RNA expression, targeting some of the world’s most intractable diseases.

why ggc invested

founder

Bill Haney

Skyhawk Therapeutics

Life Science

stage of initial investment

Seed

year of initial investment

2021

location

Washington DC

View Website

Spectrohm

Harnessing radio frequencies to power next generation imaging for securiyt, medicine and inspection

about

Harnesses radio frequencies to map the internal structure of people, packages, and objects without the hazards of X-rays, cost of MRI, or physical contact of ultrasound.

why ggc invested

founder

Tim Cargol

Spectrohm

Data Sciences

stage of initial investment

Seed

year of initial investment

2023

location

Palo Alto, California

View Website

Spiro Robotics

Robotic device to assist with intubations

about

Spiro Robotics is an early stage medical device company making difficult tracheal intubations safer and easier, with their proprietary, AI guided handheld robot.

why ggc invested

founder

Dimitri Sokolov

Spiro Robotics

Life Sciences

stage of initial investment

Seed

year of initial investment

2019

location

California

View Website

SwiftSolar

Next generation lightweight and efficient solar panels unlocking the potential of solar energy

about

Manufacturing lightweight solar panels that are more efficient than conventional panels using perovskite materials.

why ggc invested

founder

Joel Jean

SwiftSolar

GreenTech

stage of initial investment

Series A

year of initial investment

2022

location

Boston, Massachusetts

View Website

Tevard Biosciences

Novel tRNA therapeutics for genetics disorders

about

Tevard Biosciences is a pre-clinical stage biotechnology company that is pioneering the use of transfer RNA therapetuics. The company was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the goal of developing novel gene therapy approaches to cure this and many other types of genetic diseases. Initial therapeutic areas of interest include Epilepsies and other CNS disorders, Cardiovascular disorders, and Duchenne's Muscular Dystrophy.

why ggc invested

founder

Daniel Fischer

Tevard Biosciences

Life Sciences

stage of initial investment

Series C

year of initial investment

2018

location

South Carolina

View Website

The New Primal

All natural meat snacks and condiments

about

The New Primal specializes in manufacturing grass-fed, grass-finished, and pasture-raised meat snacks.

why ggc invested

founder

Jason Burke

The New Primal

stage of initial investment

Seed

year of initial investment

2021

location

Massachusetts

View Website

Thiozen

Low cost, low emmision hydrogen from sour gases

about

Developers of a system low cost, low emission solution to produce hydrogen while dramatically reducing emissions

why ggc invested

founder

Ryan Gillis

Thiozen

GreenTech

stage of initial investment

Seed

year of initial investment

2020

location

Massachusetts

View Website

Trillbit

Connectivity redefined via patented data over sound technology

about

"Developer of an authentication toolkit for passwordless solutions. Industry first FIDO conforming authentication solution using Passkeys "

why ggc invested

founder

Bhaskar Deo

Trillbit

Data Sciences

stage of initial investment

Preseed

year of initial investment

2018

location

Massachusetts

View Website

Unison

Secure and distributed programming language and platform to build next generation cloud applications

about

Developer of an open-source functional programming language and cloud platform intended to make software creation safer, simple and accessible.

why ggc invested

founder

Paul Chiusano

Unison

Data Sciences

stage of initial investment

Seed

year of initial investment

2020

location

Massachusetts

View Website

X-Cor Therapeutics

CO2 removal device for patients with lung failure

about

"X-COR Therapeutics is a medical device company creating the first commercially available CO2 removal device that uses ultra-low-blood flows for a cheaper, safer, and more accessible treatment for acute respiratory failure. Instead of pushing the failing lungs to work harder, X-COR directly reconditions blood to allow the lungs to recover. "

why ggc invested

founder

Jayon Wang

X-Cor Therapeutics

Life Sciences